Online event ‘The Life Sciences Paradox’
Innovation is crucial, yet regulatory restrictions, slow market adoption, budget cuts and increased competition are putting immense pressure on the medical companies’ investment choices. They need to face the paradox. Will you stay focused on current product lines, technologies and methodologies? Or will you put more emphasis on solving longer-term challenges in preventative, personalized and value-based healthcare?
Join us for the Life Sciences Paradox event on September 22nd together with MedTech Partners, imec and Cochlear. In 4 sessions, we’ll cover different facets of this paradox, tackling reimbursement, R&D strategies, digital innovation and clinical trials.